140 related articles for article (PubMed ID: 36651765)
1. A phase II study of perioperative treatment in gastric cancer with No.16a2/b1 lymph node metastasis: DRAGON-06 trial.
Lu S; Chen YG; Liu XW; Yang ZY; Shi M; Yuan H; Liu WT; Ni ZT; Yao XX; Hua ZC; Feng RH; He CY; Zheng YN; Wang ZQ; Sah BK; Chen MM; Zhu ZL; Li C; Zhang J; Yan M; Xia JZ; Zhu ZG; Yan C
Future Oncol; 2022 Dec; 18(39):4239-4349. PubMed ID: 36651765
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis.
Tsuburaya A; Mizusawa J; Tanaka Y; Fukushima N; Nashimoto A; Sasako M;
Br J Surg; 2014 May; 101(6):653-60. PubMed ID: 24668391
[TBL] [Abstract][Full Text] [Related]
3. [A Case of Preoperative Chemotherapy for Advanced Gastric Cancer, Laparoscopic Total Gastrectomy, Pancreaticoduodenectomy, and Para-Aortic Lymph Node Dissection].
Fukuda K; Odagiri K; Yanagimoto Y; Yamashita M; Takeyama H; Suzuki Y; Ikenaga M; Kawase T; Shimizu J; Imamura H; Dono K
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1438-1440. PubMed ID: 38303300
[TBL] [Abstract][Full Text] [Related]
4. A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002.
Ito S; Sano T; Mizusawa J; Takahari D; Katayama H; Katai H; Kawashima Y; Kinoshita T; Terashima M; Nashimoto A; Nakamori M; Onaya H; Sasako M
Gastric Cancer; 2017 Mar; 20(2):322-331. PubMed ID: 27299887
[TBL] [Abstract][Full Text] [Related]
5. [Three Cases of No. 16 Lymph Node Metastasis-Positive Gastric Cancer Successfully Treated with Chemotherapy and Para-Aortic Lymph Node Dissection].
Tamaki S; Taniguchi K; Katsuragawa H; Hataji K; Okamoto F; Hayashi T; Ishii M; Tateno Y; Kanada Y; Yagi M
Gan To Kagaku Ryoho; 2021 Dec; 48(13):2048-2051. PubMed ID: 35045489
[TBL] [Abstract][Full Text] [Related]
6. A phase II trial of Xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis.
Wang Y; Yu YY; Li W; Feng Y; Hou J; Ji Y; Sun YH; Shen KT; Shen ZB; Qin XY; Liu TS
Cancer Chemother Pharmacol; 2014 Jun; 73(6):1155-61. PubMed ID: 24748418
[TBL] [Abstract][Full Text] [Related]
7. Preoperative chemotherapy combined with para-aortic lymph node dissection has clinical value in the treatment of gastric cancer with para-aortic lymph node metastases.
Yu P; Hu C; Wang Y; Bao Z; Zhang R; Cao M; Zhang Y; Cheng X; Xu Z
BMC Surg; 2022 Nov; 22(1):401. PubMed ID: 36404297
[TBL] [Abstract][Full Text] [Related]
8. [A Case of Advanced Gastric Cancer with Para-Aortic Lymph Node Metastasis Treated with Conversion Surgery after S-1 plus Oxaliplatin Chemotherapy].
Misumi T; Suzuki T; Tazawa H; Kojima M; Kubota H; Akabane S; Hadano N; Shimizu W; Ishiyama K; Onoe T; Sudo T; Shimizu Y; Hinoi T; Tashiro H
Gan To Kagaku Ryoho; 2018 Dec; 45(13):2150-2152. PubMed ID: 30692314
[TBL] [Abstract][Full Text] [Related]
9. A good surgical field for para-aortic nodal dissection in gastric cancer by the Cattell-Braasch maneuver.
Akita M; Maeda E; Ishida R; Morikawa T; Nishimura T; Abe K; Kozuki A; Tanaka T; Kaneda K
Langenbecks Arch Surg; 2022 Nov; 407(7):3141-3146. PubMed ID: 35978050
[TBL] [Abstract][Full Text] [Related]
10. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
11. Short-term outcomes of preoperative chemotherapy with docetaxel, oxaliplatin, and S-1 for gastric cancer with extensive lymph node metastasis (JCOG1704).
Kurokawa Y; Doki Y; Kitabayashi R; Yoshikawa T; Nomura T; Tsuji K; Goto M; Cho H; Hihara J; Hiki N; Nunobe S; Mizusawa J; Boku N; Terashima M
Gastric Cancer; 2024 Mar; 27(2):366-374. PubMed ID: 38180622
[TBL] [Abstract][Full Text] [Related]
12. Role of D2 gastrectomy in gastric cancer with clinical para-aortic lymph node metastasis.
Zheng XH; Zhang W; Yang L; Du CX; Li N; Xing GS; Tian YT; Xie YB
World J Gastroenterol; 2019 May; 25(19):2338-2353. PubMed ID: 31148905
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant albumin-bound paclitaxel combined with S-1 vs. oxaliplatin combined with capecitabine after D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase III multicenter, open-label, randomized controlled clinical trial protocol.
Cheng X; Wu D; Xu N; Chen L; Yan Z; Chen P; Zhou L; Yu J; Cui J; Li W; Wang C; Feng W; Wei Y; Yu P; Du Y; Ying J; Xu Z; Yang L; Zhang Y
BMC Cancer; 2021 Jan; 21(1):56. PubMed ID: 33435909
[TBL] [Abstract][Full Text] [Related]
14. Pathological complete response at the para-aortic nodes as a possible surrogate endpoint in gastric cancer surgery with para-aortic node dissection after neoadjuvant chemotherapy.
Wada T; Yoshikawa T; Sekine S; Kamiya A; Hayashi T; Otsuki S; Yamagata Y; Katai H
Eur J Surg Oncol; 2022 Feb; 48(2):333-338. PubMed ID: 34284903
[TBL] [Abstract][Full Text] [Related]
15. [Conversion Surgery Performed after SOX plus Nivolumab Therapy for Advanced Gastric Cancer with Para-Aortic Lymph Node Metastasis].
Okuda T; Odagiri K; Yanagimoto Y; Yamashita M; Takeyama H; Suzuki Y; Ikenaga M; Kawase T; Shimizu J; Imamura H; Dono K
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1671-1673. PubMed ID: 38303168
[TBL] [Abstract][Full Text] [Related]
16. A pilot study of an individualized comprehensive treatment for advanced gastric cancer with para-aortic lymph node metastasis.
He Q; Ma L; Li Y; Li G
BMC Gastroenterol; 2016 Jan; 16():8. PubMed ID: 26782354
[TBL] [Abstract][Full Text] [Related]
17. A Phase II study of preoperative chemotherapy with docetaxel, oxaliplatin and S-1 in gastric cancer with extensive lymph node metastasis (JCOG1704).
Sato Y; Kurokawa Y; Doki Y; Mizusawa J; Tanaka K; Katayama H; Boku N; Yoshikawa T; Terashima M;
Future Oncol; 2020 Feb; 16(4):31-38. PubMed ID: 31920105
[No Abstract] [Full Text] [Related]
18. Neoadjuvant docetaxel, oxaliplatin and S-1 therapy for the patients with large type 3 or type 4 gastric cancer (OGSG1902): protocol of a multi-center, phase II study.
Endo S; Terazawa T; Goto M; Tanaka R; Kato T; Fujitani K; Kawakami H; Sakai D; Kurokawa Y; Tsujinaka T; Shimokawa T; Satoh T
BMC Cancer; 2022 Jul; 22(1):811. PubMed ID: 35870893
[TBL] [Abstract][Full Text] [Related]
19. [A Case of Advanced Gastric Cancer with Para-Aortic Lymph Node Dissection after Neoadjuvant Chemotherapy].
Ogawa T; Choda Y; Ninomiya M; Nagai Y; Mimura N; Miyake S; Ishida M; Matsukawa H; Ojima Y; Idani H; Shiozaki S; Okajima M
Gan To Kagaku Ryoho; 2016 Nov; 43(12):2205-2207. PubMed ID: 28133270
[TBL] [Abstract][Full Text] [Related]
20. GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study.
Glehen O; Passot G; Villeneuve L; Vaudoyer D; Bin-Dorel S; Boschetti G; Piaton E; Garofalo A
BMC Cancer; 2014 Mar; 14():183. PubMed ID: 24628950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
